Heart device deployed to halt blood clots that spur strokes

UW Medicine is early adopter of technology for atrial-fibrillation patients

Seattle Times  |  Updated 11:30 AM, 08.21.2015

Posted in: Healthcare

  • The device was approved in February 2015 by the U.S. Food and Drug Administration. Courtesy of Boston Scientific
The UW Medicine Regional Heart Center recently became one of the first cardiology programs in the nation to deploy a lantern-shaped heart device intended to halt the formation of potentially blood clots.

The "Watchman" device is for people who live with atrial fibrillation, a common condition in which the heartbeat quickens and gets out of sync. The condition can lead to blood clots forming and traveling to the brain, causing stroke. The device helps create a barrier that stops clots from forming.

See the full story at Seattle Times  

Tagged with: heart, device
Contact us about this story.